{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:41:26Z","timestamp":1772066486361,"version":"3.50.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Peyronie\u2019s disease (PD) is a connective tissue disorder that affects the penis and is characterized by abnormal collagen structure in the penile tunica albuginea, resulting in plaque formation and penile deformity. PD\u2019s overall prevalence is estimated at 3.2% to 8.9%, with rates as high as 20.3% among men with type 2 diabetes mellitus (DM). However, the characteristics of DM associated with PD complications remain unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To explore clinical associations between DM characteristics and PD complications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective analysis of patients with DM and PD who presented at our institution between 2007 and 2022. We examined patients\u2019 clinical histories, DM- and PD-related clinical parameters, and complications. Penile deformities were assessed through physical examination, photographs, and penile Doppler ultrasound. Patients were categorized into subgroups based on age of DM onset: early (&amp;lt;45\u00a0years), average (45-65\u00a0years), and late (&amp;gt;65\u00a0years).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcomes<\/jats:title>\n                  <jats:p>Outcomes included effects of DM characteristics on PD development, progression, and severity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 197 patients were included in the evaluation. Early-onset diabetes and elevated hemoglobin A1c (HbA1c) levels exhibited significant correlations with the early development of PD (\u03c1 =\u20090.66, P\u2009&amp;lt;\u2009.001, and \u03c1 =\u2009\u20130.24, P\u2009&amp;lt;\u2009.001, respectively). Furthermore, having DM at an early age was associated with the occurrence of penile plaque (\u03c1 =\u2009\u20130.18, P\u2009=\u2009.03), and there were no significant differences in plaque dimensions (\u03c1 =\u2009\u20130.29, P\u2009=\u2009.053). A rise in HbA1c levels after the initial PD diagnosis displayed positive correlations with the formation of penile plaque (\u03c1 =\u20090.22, P\u2009&amp;lt;\u2009.006).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Implications<\/jats:title>\n                  <jats:p>These findings emphasize the need for comprehensive assessments and personalized treatment strategies for individuals with DM and PD. Enhanced management approaches can improve outcomes for those facing both challenges.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths and Limitations<\/jats:title>\n                  <jats:p>Limitations include the single-site retrospective design with potential selection bias, inaccuracies in medical record data, and challenges in controlling confounding variables.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study highlights that early-onset diabetes and poor diabetes control, as indicated by a subsequent rise in HbA1c levels following PD diagnosis, are significantly correlated with the onset and severity of PD. Revealing the mechanisms behind these findings will help us develop better management strategies for individuals with DM and PD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jsxmed\/qdae069","type":"journal-article","created":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:26:23Z","timestamp":1720311983000},"page":"716-722","source":"Crossref","is-referenced-by-count":3,"title":["Early-onset and uncontrolled diabetes mellitus factors correlate with complications of Peyronie\u2019s disease"],"prefix":"10.1093","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8913-5822","authenticated-orcid":false,"given":"Serkan","family":"Karakus","sequence":"first","affiliation":[{"name":"The James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins University School of Medicine , Baltimore, MD 21287 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9000-304X","authenticated-orcid":false,"given":"Selman","family":"Unal","sequence":"additional","affiliation":[{"name":"The James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins University School of Medicine , Baltimore, MD 21287 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisy","family":"Dai","sequence":"additional","affiliation":[{"name":"The James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins University School of Medicine , Baltimore, MD 21287 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crystal","family":"Joseph","sequence":"additional","affiliation":[{"name":"The James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins University School of Medicine , Baltimore, MD 21287 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Du Comb","sequence":"additional","affiliation":[{"name":"The James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins University School of Medicine , Baltimore, MD 21287 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason A","family":"Levy","sequence":"additional","affiliation":[{"name":"The James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins University School of Medicine , Baltimore, MD 21287 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Hawksworth","sequence":"additional","affiliation":[{"name":"The James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins University School of Medicine , Baltimore, MD 21287 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur L","family":"Burnett","sequence":"additional","affiliation":[{"name":"The James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins University School of Medicine , Baltimore, MD 21287 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,7,6]]},"reference":[{"issue":"6","key":"2024080207042585400_ref1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/ajcp\/45.6.670","article-title":"Peyronie\u2019s disease","volume":"45","author":"Smith","year":"1966","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2024080207042585400_ref2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1743-6109.2006.00344.x","article-title":"Defining the clinical characteristics of Peyronie\u2019s disease in young men","volume":"4","author":"Deveci","year":"2007","journal-title":"J Sex Med"},{"issue":"6 pt 1","key":"2024080207042585400_ref3","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","article-title":"Subjective and objective analysis of the prevalence of Peyronie\u2019s disease in a population of men presenting for prostate cancer screening","volume":"171","author":"Mulhall","year":"2004","journal-title":"J Urol"},{"issue":"6","key":"2024080207042585400_ref4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/sj.ijir.3901247","article-title":"Incidentally diagnosed Peyronie\u2019s disease in men presenting with erectile dysfunction","volume":"16","author":"Kadioglu","year":"2004","journal-title":"Int J Impot Res"},{"issue":"2","key":"2024080207042585400_ref5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.esxm.2019.11.002","article-title":"Prevalence, risk factors, and erectile dysfunction associated with Peyronie\u2019s disease among men seeking urological care","volume":"8","author":"Segundo","year":"2020","journal-title":"Sex Med"},{"issue":"3","key":"2024080207042585400_ref6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2164\/jandrol.111.012948","article-title":"Association between Peyronie disease and low serum testosterone levels: detection and therapeutic considerations","volume":"33","author":"Cavallini","year":"2012","journal-title":"J Androl"},{"issue":"4","key":"2024080207042585400_ref7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2164\/jandrol.109.008730","article-title":"Amelioration of penile fibrosis: myth or reality","volume":"31","author":"El-Sakka","year":"2010","journal-title":"J Androl"},{"issue":"3","key":"2024080207042585400_ref8","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/01.ju.0000170231.51306.32","article-title":"Peyronie\u2019s disease in diabetic patients being screened for erectile dysfunction","volume":"174","author":"El-Sakka","year":"2005","journal-title":"J Urol"},{"issue":"4","key":"2024080207042585400_ref9","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.urology.2012.12.030","article-title":"Improvement of chronic Peyronie\u2019s disease symptoms after diabetic compensation: a retrospective study","volume":"81","author":"Cavallini","year":"2013","journal-title":"Urology"},{"issue":"3","key":"2024080207042585400_ref10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4103\/UA.UA_164_18","article-title":"Peyronie\u2019s disease is common in poorly controlled diabetics but is not associated with the metabolic syndrome","volume":"11","author":"Habous","year":"2019","journal-title":"Urol Ann"},{"issue":"4","key":"2024080207042585400_ref11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000280897","article-title":"Classification of congenital and acquired penile deviation","volume":"38","author":"Kel\u00e2mi","year":"1983","journal-title":"Urol Int"},{"issue":"1","key":"2024080207042585400_ref12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-5347(17)35996-7","article-title":"Standardization of penile blood flow parameters in normal men using intracavernous prostaglandin E1 and visual sexual stimulation","volume":"149","author":"Lee","year":"1993","journal-title":"J Urol"},{"key":"2024080207042585400_ref13"},{"issue":"1","key":"2024080207042585400_ref14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2337\/cd17-0119","article-title":"Standards of medical care in diabetes\u20142018: abridged for primary care providers","volume":"36","author":"American Diabetes Association","year":"2018","journal-title":"Clin Diabetes."},{"key":"2024080207042585400_ref15"},{"issue":"6","key":"2024080207042585400_ref16","first-page":"e26180","article-title":"Glycemic control for type 2 diabetes mellitus patients: a systematic review","volume":"14","author":"Bin Rakhis","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"2024080207042585400_ref17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.1464-410x.2001.02260.x","article-title":"Prevalence of undiagnosed diabetes mellitus in male erectile dysfunction","volume":"88","author":"Sairam","year":"2001","journal-title":"BJU Int"},{"key":"2024080207042585400_ref18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2012.12.026","article-title":"The long and winding road to optimal HbA1c measurement","volume":"418","author":"Little","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"2","key":"2024080207042585400_ref19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/01.ju.0000097498.34847.7c","article-title":"Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronie\u2019s disease","volume":"171","author":"Usta","year":"2004","journal-title":"J Urol"},{"issue":"2","key":"2024080207042585400_ref20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1464-410X.2007.06611.x","article-title":"Diabetes mellitus is associated with severe Peyronie\u2019s disease","volume":"99","author":"Kendirci","year":"2007","journal-title":"BJU Int"},{"issue":"5","key":"2024080207042585400_ref21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2164\/jandrol.110.011031","article-title":"Factors affecting the degree of penile deformity in Peyronie disease: an analysis of 1001 patients","volume":"32","author":"Kadioglu","year":"2011","journal-title":"J Androl"},{"key":"2024080207042585400_ref22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/2156-7514.103053","article-title":"US imaging in Peyronie\u2019s disease","volume":"2","author":"Kalokairinou","year":"2012","journal-title":"J Clin Imaging Sci"},{"issue":"10","key":"2024080207042585400_ref23","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1111\/j.1743-6109.2009.01438.x","article-title":"Penile sonographic and clinical characteristics in men with Peyronie\u2019s disease","volume":"6","author":"Smith","year":"2009","journal-title":"J Sex Med"},{"issue":"2","key":"2024080207042585400_ref24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1743-6109.2010.02072.x","article-title":"Risk factors of Peyronie\u2019s disease: what does our clinical experience show?","volume":"8","author":"Casab\u00e9","year":"2011","journal-title":"J Sex Med"},{"issue":"4","key":"2024080207042585400_ref25","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0022-5347(01)64223-X","article-title":"Peyronie\u2019s disease is associated with an increase in transforming growth factor-beta protein expression","volume":"158","author":"El-Sakka","year":"1997","journal-title":"J Urol"},{"issue":"2","key":"2024080207042585400_ref26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ijir.3901518","article-title":"The prevalence of Peyronie\u2019s disease in diabetic patients with erectile dysfunction","volume":"19","author":"Arafa","year":"2007","journal-title":"Int J Impot Res"},{"issue":"4","key":"2024080207042585400_ref27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.sxmr.2019.02.004","article-title":"Pathophysiology and future therapeutic perspectives for resolving fibrosis in Peyronie\u2019s disease","volume":"7","author":"Milenkovic","year":"2019","journal-title":"Sex Med Rev"},{"issue":"suppl 1","key":"2024080207042585400_ref28","doi-asserted-by":"crossref","first-page":"s17","DOI":"10.1185\/0300799009117035","article-title":"Diabetes, hypertension and erectile dysfunction","volume":"16","author":"Ledda","year":"2000","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"2024080207042585400_ref29","doi-asserted-by":"crossref","first-page":"166044","DOI":"10.1016\/j.bbadis.2020.166044","article-title":"Diabetic fibrosis","volume":"1867","author":"Tuleta","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"2024080207042585400_ref30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/2040622314548679","article-title":"Early onset type 2 diabetes: risk factors, clinical impact and management","volume":"5","author":"Wilmot","year":"2014","journal-title":"Ther Adv Chronic Dis"},{"issue":"5","key":"2024080207042585400_ref31","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s11010-021-04086-5","article-title":"Role of Wnt signaling pathways in type 2 diabetes mellitus","volume":"476","author":"Chen","year":"2021","journal-title":"Mol Cell Biochem"},{"issue":"12","key":"2024080207042585400_ref32","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1111\/j.1743-6109.2010.01915.x","article-title":"The relationship between androgens, regulators of collagen metabolism, and Peyronie\u2019s disease: a case control study","volume":"7","author":"Karavitakis","year":"2010","journal-title":"J Sex Med"},{"issue":"6","key":"2024080207042585400_ref33","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/j.1743-6109.2009.01250.x","article-title":"Testosterone deficiency and Peyronie\u2019s disease: pilot data suggesting a significant relationship","volume":"6","author":"Moreno","year":"2009","journal-title":"J Sex Med"},{"issue":"2","key":"2024080207042585400_ref34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/dme.13977","article-title":"Testosterone deficiency in men with type 2 diabetes: pathophysiology and treatment","volume":"37","author":"Gianatti","year":"2020","journal-title":"Diabet Med"},{"issue":"3","key":"2024080207042585400_ref35","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/jsm.12805","article-title":"Low testosterone has a similar prevalence among men with sexual dysfunction due to either Peyronie\u2019s disease or erectile dysfunction and does not correlate with Peyronie\u2019s disease severity","volume":"12","author":"Kirby","year":"2015","journal-title":"J Sex Med"},{"issue":"11","key":"2024080207042585400_ref36","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1442-2042.2011.02842.x","article-title":"Does testosterone deficiency exaggerate the clinical symptoms of Peyronie\u2019s disease?","volume":"18","author":"Nam","year":"2011","journal-title":"Int J Urol"},{"issue":"3","key":"2024080207042585400_ref37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.juro.2018.05.004","article-title":"Erectile dysfunction: AUA guideline","volume":"200","author":"Burnett","year":"2018","journal-title":"J Urol"},{"key":"2024080207042585400_ref38","volume-title":"Sexual and Reproductive Health: EAU Guidelines","author":"Salonia","year":"2023"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/21\/8\/716\/58710724\/qdae069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/21\/8\/716\/58710724\/qdae069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T07:15:30Z","timestamp":1722582930000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/21\/8\/716\/7708630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,6]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,7,6]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jsxmed\/qdae069","relation":{},"ISSN":["1743-6095","1743-6109"],"issn-type":[{"value":"1743-6095","type":"print"},{"value":"1743-6109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,7,6]]}}}